The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
Michiel A. J. van de Sande(Leiden University Medical Center), Eric L. Staals(Istituto Ortopedico Rizzoli), John H. Healey(Memorial Sloan Kettering Cancer Center), Hans Gelderblom(Leiden University Medical Center), Sebastian Bauer(Science for Life Laboratory), Julio López‐Bastida(Daiichi Sankyo (Germany)), Emanuela Palmerini(Istituto Ortopedico Rizzoli), Geert Spierenburg(Leiden University Medical Center), Xin Ye(Guangzhou Center for Disease Control and Prevention), Petra Laeis(Daiichi Sankyo (Germany)), Nicholas M. Bernthal(Harvard University), Eva‐Maria Fronk(Daiichi Sankyo (Germany))
Cited by 49
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k